Elevated adiposity and altered IGF-1 levels are also linked with OC, where insulin’s tumor-enhancing effects often activate the PI3K/Akt-mTOR pathway, a key regulator of cell growth, proliferation, and survival [49,50,51,52,53,54,55]. The gene discussed is MTOR; the disease is neoplasm.